Gucci-Owner Kering Nears “Point Of Stabilization” After Brutal Luxury Downturn
Gucci owner Kering SA reported fourth-quarter earnings that showed a modest improvement following a prolonged downturn in the luxury market that rippled through Asia and the West in recent years. Some Wall Street analysts are asking if the worst is over.
Kering reported a 12% drop in fourth-quarter revenues to 4.39 billion euros—just slightly above Bloomberg Consensus’s forecast of 4.24 billion euros. Analysts had expected revenues for the quarter to slide by around 13.3%.
Gucci, which contributes about two-thirds of Kering’s profit, recorded a 24% drop in revenue on a comparable basis during the quarter, exceeding the 22% estimate. Sagging Chinese sales have hit the high-end fashion group.
Here’s a snapshot of Kering’s fourth-quarter earnings (courtesy of Bloomberg):
Comparable revenue -12%, estimate -13.3% (Bloomberg Consensus)
Gucci revenue on a comparable basis -24%, estimate -22%
Yves Saint Laurent revenue on a comparable basis -8%, estimate -10.2%
Bottega Veneta revenue on a comparable basis +12%, estimate +4.91%
Other Houses revenue on a comparable basis -4%, estimate -12%
Eyewear & corporate revenue on a comparable basis +10%, estimate +6.14%
Revenue EU4.39 billion, -12% y/y, estimate EU4.24 billion
Gucci revenue EU1.92 billion, -24% y/y, estimate EU1.95 billion
Yves Saint Laurent revenue EU770 million, -7.8% y/y, estimate EU738.2 million
Bottega Veneta revenue EU480 million, +11% y/y, estimate EU452.1 million
Other Houses revenue EU818 million, -4.1% y/y, estimate EU786.3 million
Eyewear & corporate revenue EU434 million, +19% y/y, estimate EU405 million
Kering CEO Francois-Henri Pinault told investors the group had reached a “point of stabilization, from which we will gradually resume growth.”
“Gucci will come back. I have absolutely no doubts about this,” Pinault told analysts on an earnings call.
RBC Capital Markets analyst Piral Dadhania told clients, “We believe the worst may be behind us, although the timing for a potential reset remains unclear at this stage.”
Dadhania added that today’s earnings should reassure investors that “trends are modestly improving against low sentiment.”
Kering’s 2024 results are symptoms of a global luxury downturn:
Comparable revenue -12%, estimate -11.6%
Revenue EU17.19 billion, -12% y/y, estimate EU17.01 billion
Recurring operating income EU2.55 billion, -46% y/y, estimate EU2.48 billion
Gucci recurring operating income EU1.61 billion, -51% y/y, estimate EU1.59 billion
Yves Saint Laurent recurring operating income EU593 million, -39% y/y, estimate EU599.5 million
Bottega Veneta recurring operating income EU255 million, -18% y/y, estimate EU244.3 million
Other Houses recurring operating loss EU9 million vs. profit EU212 million y/y, estimate loss EU49.2 million
Recurring operating margin 14.9% vs. 24.3% y/y, estimate 14.7%
Ebitda EU4.67 billion, -29% y/y, estimate EU4.16 billion
Ebitda margin 27.1% vs. 33.6% y/y, estimate 25.1% * Net income EU1.13 billion, -62% y/y, estimate EU1.31 billion
Dividend per share EU6, estimate EU6.53
Here are the key takeaways from the earnings results provided by other Wall Street analysts (courtesy of Bloomberg):
Morgan Stanley (equal-weight)
Kering saw a weak end to the year but at the top line, its performance was roughly in line, says analyst Edouard Aubin
Its operating income should come as a relief to the market given worries about the impact of operating deleverage on the group’s profitability
Jefferies (hold)
Momentum improved in the fourth quarter as expected, writes analyst James Grzinic, adding that “more positively minded souls” will focus on what Kering called a “highly encouraging” performance at Gucci’s new leather goods and iconic lines
Notes there is no explicit guidance for 2025 or reference to current trading
Morningstar (buy)
Analyst Jelena Sokolova notes that all brands in the group improved performance sequentially apart from Gucci, which remains the biggest problem
Lack of Gucci improvement doesn’t come as a big surprise, given the departure of designer Sabato De Sarno and weak brand momentum trends online
Bloomberg Intelligence
- Kering’s 2024 results show signs of stabilization in terms of the pace of declines across its brands, including Gucci, writes analyst Deborah Aitken
Kering shares in Paris jumped as much as 6.7%. Shares are down 73% since peaking in mid-2021.
Meanwhile, Kering rivals, including LVMH Moët Hennessy Louis Vuitton SE, the world’s largest luxury group, have also been hit by a broad luxury slowdown. However, Swiss luxury group Richemont reported possible green shoots last month.
Bloomberg Markets Live reporters Kit Rees and Michael Msika asked last month if “luxury bulls jump the gun”?
We suspect so, but the sector has encouraging signs of stabilization—conditions that would attract the bottom-feeder investor.
Tyler Durden Tue, 02/11/2025 – 07:20
Source: https://freedombunker.com/2025/02/11/gucci-owner-kering-nears-point-of-stabilization-after-brutal-luxury-downturn/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
